|Bid||0.00 x 800|
|Ask||262.29 x 900|
|Day's Range||258.52 - 265.27|
|52 Week Range||103.75 - 284.00|
|Beta (5Y Monthly)||1.00|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Halozyme Therapeutics boosted its EPS and sales guidance for the year, buoyed by partnerships with big drugmakers such as Roche and Johnson & Johnson, sparking HALO stock to a record high.
Halozyme (HALO) reports better-than-expected third-quarter results. The company raises outlook for the year anticipating higher royalties.
Shares of argenx (NASDAQ:ARGX) decreased 6.1% in pre-market trading after the company reported Q3 results.Quarterly Results Earnings per share were down 450.00% year over year to ($3.96), which missed the estimate of ($2.81).Revenue of $8,968,000 declined by 5.78% year over year, which missed the estimate of $16,850,000.Guidance argenx hasn't issued any earnings guidance for the time being.Revenue guidance hasn't been issued by the company for now.How To Listen To The Conference Call Date: Oct 22, 2020View more earnings on ARGXTime: 08:30 AMET Webcast URL: https://event.on24.com/eventRegistration/EventLobbyServlet?target=reg20.jsp&referrer=https%3A%2F%2Fwww.argenx.com%2F&eventid=2738263&sessionid=1&key=F469E4B3D87911A523DAB8276C85E03C®Tag=&sourcepage=registerRecent Stock Performance 52-week high: $284.0052-week low: $103.75Price action over last quarter: Up 4.79%Company Profile argenx SE is a clinical stage biotechnology company. It is engaged in the business of developing a pipeline of differentiated antibody-based therapies for the treatment of severe autoimmune diseases and cancer. Its product pipeline includes product candidates such as ARGX-111, ARGX-109, ARGX-115, ARGX-112, and others. The company operates in the Netherlands, Germany, Denmark, Belgium, Switzerland, the United States, and Luxembourg. It derives the majority of its revenues from Switzerland.See more from Benzinga * Options Trades For This Crazy Market: Get Benzinga Options to Follow High-Conviction Trade Ideas * Earnings Scheduled For October 22, 2020 * Stocks That Hit 52-Week Highs On Monday(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.